Status:
ENROLLING_BY_INVITATION
Project CASCADE: Community and Academic Synergy for Cancer Survivorship Care Delivery Enhancement
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cancer Survivorship
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to implement a clinic-level cancer survivorship care delivery intervention in partnership with community health center clinicians, patients, and community representatives ...
Eligibility Criteria
Inclusion
- Inclusion Criteria (participants):
- at least one visit to the Community Health Centers (CHCs) in the prior year
- Exclusion Criteria (participants):
- \- no history of cancer recorded in the problem list or past medical history in the medical record
- Inclusion Criteria (clinicians):
- employed clinicians (e.g. physicians, nurses, pharmacists, or other allied health professionals) and non-clinician staff of the participating CHC clinics
Exclusion
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2029
Estimated Enrollment :
5584 Patients enrolled
Trial Details
Trial ID
NCT06883838
Start Date
September 1 2025
End Date
May 31 2029
Last Update
October 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center, Houston
Houston, Texas, United States, 77030